Download Citation
Article Source:
Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer
Lin WH,
Yeh TK,
Jiaang WT,
Yen KJ,
Chen CH,
et al.
(2014)
Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer.
PLOS ONE 9(1): e83160.
https://doi.org/10.1371/journal.pone.0083160